Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ, Taiwan Community-Based Cancer Screening Project Group 2002. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Eng J Med. 2002;347:168–74.
Durantel D, Zoulim F. New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus. J Hepatol. 2016;64:S117–31.
Article CAS PubMed Google Scholar
Pei Y, Wang C, Yan SF, Liu G. Past, current, and future developments of therapeutic agents for treatment of chronic hepatitis B virus infection. J Med Chem. 2017;60:6461–79.
Article CAS PubMed Google Scholar
Beck J, Nassal M. Hepatitis B virus replication. World J Gastroenterol. 2007;13:48–64.
Article CAS PubMed PubMed Central Google Scholar
Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology. 2015;479-480:672–86.
Article CAS PubMed Google Scholar
Suzuki M, Kondo S, Yamasaki M, Matsuda N, Nomoto A, Suzuki T, Saito I, Kanegae Y. Efficient genome replication of hepatitis B virus using adenovirus vector: a compact pregenomic RNA-expression unit. Sci Rep. 2017;7:41851.
Article CAS PubMed PubMed Central Google Scholar
Takizawa N, Yamasaki M. Current landscape and future prospects of antiviral drugs derived from microbial products. J Antibiot. 2017;71:45–52.
Yamasaki M, Matsuda N, Matoba K, Kondo S, Kanegae Y, Saito I, Nomoto A. Acetophenone 4-nitrophenylhydrazone inhibits Hepatitis B virus replication by modulating capsid assembly. Virus Res. 2021;306:198565.
Article CAS PubMed Google Scholar
Nishio M, Tomatsu K, Konishi M, Tomita K, Oki T, Kawaguchi H, Clardy J. Karnamicin, a complex of new antifungal antibiotics. I. Taxonomy, fermentation, isolation and physico-chemical and biological properties. J Antibiot. 1989;42:852–68.
Urban M, McMillan DJ, Canning G, Newell A, Brown E, Mills JS, Jupp R. In vitro activity of hepatitis B virus polymerase: requirement for distinct metal ions and the viral epsilon stem-loop. J Gen Virol. 1998;79:1121–31.
Article CAS PubMed Google Scholar
Toyoda T, Wang Y, Wen Y, Tanaka Y. Fluorescence-based biochemical analysis of human hepatitis B virus reverse transcriptase activity. Anal Biochem. 2020;597:113642.
Article CAS PubMed Google Scholar
Chang LJ, Hirsch RC, Ganem D, Varmus HE. Effects of insertional and point mutations on the functions of the duck hepatitis B virus polymerase. J Virol. 1990;64:5553–8.
Article CAS PubMed PubMed Central Google Scholar
Wei X, Peterson DL. Expression, purification, and characterization of an active RNase H domain of the hepatitis B viral polymerase. J Biol Chem. 1996;271:32617–22.
Article CAS PubMed Google Scholar
Lu G, Lomonosova E, Cheng X, Moran EA, Meyers MJ, Le Grice SF, Thomas CJ, Jiang JK, Meck C, Hirsch DR, D’Erasmo MP, Suyabatmaz DM, Murelli RP, Tavis JE. Hydroxylated tropolones inhibit hepatitis B virus replication by blocking viral ribonuclease H activity. Antimicrob Agents Chemother. 2015;59:1070–9.
Article PubMed PubMed Central Google Scholar
Jiang B, Hildt E. Intracellular trafficking of HBV particles. Cells. 2020;9:2023.
Article CAS PubMed PubMed Central Google Scholar
Lenhoff RJ, Summers J. Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus. J Virol. 1994;68:4565–71.
Article CAS PubMed PubMed Central Google Scholar
Ning X, Nguyen D, Mentzer L, Adams C, Lee H, Ashley R, Hafenstein S, Hu J. Secretion of genome-free hepatitis B virus - single strand blocking model for virion morphogenesis of para-retrovirus. PLoS Pathog. 2011;7:e1002255.
Article CAS PubMed PubMed Central Google Scholar
Bai L, Zhang X, Kozlowski M, Li W, Wu M, Liu J, Chen L, Zhang J, Huang Y, Yuan Z. Extracellular hepatitis B Virus RNAs are heterogeneous in length and circulate as capsid-antibody complexes in addition to virions in chronic hepatitis B patients. J Virol. 2018;92:e00798–18.
Article CAS PubMed PubMed Central Google Scholar
Yu Z, Huang JP, Yang J, Liu C, Yan Y, Wang L, Zhao J, Chen Y, Xiang W, Huang SX. Discovery and biosynthesis of karnamicins as angiotensin converting enzyme inhibitors. Nat Commun. 2023;14:209.
Article CAS PubMed PubMed Central Google Scholar
Tsurumi Y, Ueda H, Hayashi K, Takase S, Nishikawa M, Kiyoto S, Okuhara M. WS75624 A and B, new endothelin converting enzyme inhibitors isolated from Saccharothrix sp. No. 75624. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities. J Antibiot. 1995;48:1066–72.
Yoshimura S, Tsurumi Y, Takase S, Okuhara M. WS75624 A and B, new endothelin converting enzyme inhibitors isolated from Saccharothrix sp. No. 75624. II. Structure elucidation of WS75624 A and B. J Antibiot. 1995;48:1073–5.
Kimura T, Inahashi Y, Matsuo H, Suga T, Iwatsuki M, Shiomi K, Takahashi Y, Ōmura S, Nakashima T. Pyrizomicin A and B: structure and bioactivity of new thiazolyl pyridines from Lechevalieria aerocolonigenes K10-0216. J Antibiot. 2018;71:606–8.
Guo F, Zhao Q, Sheraz M, Cheng J, Qi Y, Su Q, Cuconati A, Wei L, Du Y, Li W, Chang J, Guo JT. HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways. PLoS Pathog. 2017;13:e1006658.
Comments (0)